Lemaitre Vascular (LMAT) Operating Leases (2019 - 2026)

Lemaitre Vascular (LMAT) has 8 years of Operating Leases data on file, last reported at $20.9 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $20.9 million, up 42.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.9 million (up 42.1% YoY), and the FY2025 annual result was $14.0 million, down 8.07% from the prior year.
• Operating Leases climbed to $20.9 million in Q1 2026 per LMAT's latest filing, from $14.0 million in the prior quarter.
• Over five years, Operating Leases peaked at $20.9 million in Q1 2026 and troughed at $14.0 million in Q4 2025.
• A 5-year average of $16.0 million and a median of $15.4 million in 2022 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2025 and 2026: Operating Leases retreated 21.93% in 2025, then surged 42.1% in 2026.
• A 5-year view of Operating Leases shows it stood at $14.7 million in 2022, then advanced by 13.01% to $16.6 million in 2023, then declined by 8.37% to $15.2 million in 2024, then fell by 8.07% to $14.0 million in 2025, then jumped by 49.6% to $20.9 million in 2026.
• Business Quant data shows LMAT's Operating Leases at $20.9 million in Q1 2026, $14.0 million in Q4 2025, and $14.4 million in Q3 2025.